Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe
Home
Issues
2022
May 2022 - Vol 15 No 3
March 2022 - Vol 15 No 2
January 2022 - Vol 15 No 1 – Online Only
2021
November 2021 - Vol 14 No 7
October 2021 - Vol 14 No 6 | Biosimilars
September 2021 - Vol 14 No 5
July 2021 - Vol 14 No 4
May 2021 - Vol 14 No 3
March 2021 - Vol 14 No 2
January 2021 - Vol 14 No 1
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
Issue Archive
Special Issues
Supplements
ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
Checkmate 9LA
Checkmate 227
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2021 Wrap-Up - Breast Cancer
Web Exclusives
Ovarian Cancer Overview
Interview with the Innovators
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
Charlie Dawson
Authored Items
Study Shows mRNA COVID-19 Vaccine Safe and Effective in Patients with Cancer Receiving Active Treatment
Charlie Dawson
TOP - March 2022 Vol 15, No 2
in
COVID-19 & Cancer
mRNA COVID-19 Vaccine Appears Safe and Effective in Patients with Cancer Receiving Active Treatment
Charlie Dawson
TOP - March 2022 Vol 15, No 2
in
AVBCC Summit Highlights
Pilot Program Highlights Benefits of Advance Care Planning During the COVID-19 Pandemic
Charlie Dawson
TOP - January 2022 Vol 15, No 1 – Online Only
in
COVID-19 & Cancer
Drug Price Reform: The Implications for 2022 and Beyond
Charlie Dawson
TOP - January 2022 Vol 15, No 1 – Online Only
in
AVBCC Summit Highlights
NCCN Risk Classification Suboptimal for Some African-American Men with Prostate Cancer
Charlie Dawson
TOP - November 2021 Vol 14, No 7
in
Prostate Cancer
Targeted Radiotherapy Prolongs Survival in Patients with Advanced Prostate Cancer
Charlie Dawson
TOP - November 2021 Vol 14, No 7
in
Prostate Cancer
Survey of Oncologists Reveals Ongoing Misconceptions and Concerns Regarding Biosimilars
Charlie Dawson
TOP - October 2021 Vol 14, No 6 | Biosimilars
in
ASCO Quality Care Symposium
,
Biosimilars
Analysis of Healthcare Claims Shows Encouraging Trend in the Use of Trastuzumab Biosimilars
Charlie Dawson
TOP - October 2021 Vol 14, No 6 | Biosimilars
in
ASCO Quality Care Symposium
,
Biosimilars
Pharmacist-Driven Intervention Leads to Significant Increase in Biosimilar Adoption
Charlie Dawson
TOP - October 2021 Vol 14, No 6 | Biosimilars
in
ASCO Quality Care Symposium
,
Biosimilars
Multidisciplinary Team Approach Leads to Rapid Biosimilar Adoption in Community Oncology Practice
Charlie Dawson
TOP - October 2021 Vol 14, No 6 | Biosimilars
in
Best Practices
,
Biosimilars
Tucatinib plus Trastuzumab and Capecitabine Triplet Maintains Survival Benefit in HER2-Positive Metastatic Breast Cancer: Updated Results from HER2CLIMB Trial
Charlie Dawson
TOP - September 2021 Vol 14, No 5
in
Breast Cancer
The Impact of Racial Disparities in Cancer Care
Charlie Dawson
TOP - September 2021 Vol 14, No 5
in
Disparities in Oncology
New Opportunities in Clinical Trials and Drug Development After COVID-19
Charlie Dawson
TOP - July 2021 Vol 14, No 4
in
HOPA Highlights
Dismantling Structural Racism in Oncology Pharmacy
Charlie Dawson
TOP - July 2021 Vol 14, No 4
in
HOPA Highlights
Optimizing Opioid Therapy in Patients with Cancer Pain
Charlie Dawson
TOP - July 2021 Vol 14, No 4
in
HOPA Highlights
Updates on the Use of Anticoagulants for Cancer-Associated Thromboembolism
Charlie Dawson
TOP - July 2021 Vol 14, No 4
in
HOPA Highlights
Immunotherapy Continues to Transform the Treatment Landscape for Advanced NSCLC
Charlie Dawson
TOP - July 2021 Vol 14, No 4
in
HOPA Highlights
Advances in the Treatment of HER2-Positive Metastatic Breast Cancer
Charlie Dawson
TOP - July 2021 Vol 14, No 4
in
HOPA Highlights
Improving Response Rates in Metastatic Urothelial Cancer: The Role of Targeted Therapies
Charlie Dawson
TOP - July 2021 Vol 14, No 4
in
HOPA Highlights
Daratumumab in Newly Diagnosed Multiple Myeloma: Understanding the Pros and Cons
Charlie Dawson
TOP - July 2021 Vol 14, No 4
in
HOPA Highlights
Vodobatinib Effective in Patients with CML Regardless of Previous Ponatinib Therapy
Charlie Dawson
TOP - March 2021 Vol 14, No 2
in
Emerging Therapies
Research Reveals Barriers to Clinical Trial Participation
Charlie Dawson
TOP - March 2021 Vol 14, No 2
in
Clinical Trials
Intervention Improves Quality of Life for Patients Experiencing Financial Toxicity
Charlie Dawson
TOP - March 2021 Vol 14, No 2
in
Value-Based Care
Glofitamab Step-Up Dosing Leads to High Response Rates in Relapsed or Refractory NHL
Charlie Dawson
TOP - March 2021 Vol 14, No 2
in
ASH 2020 Highlights
Providing Quality Care to Patients During the COVID-19 Pandemic: Lessons Learned
Charlie Dawson
TOP - January 2021 Vol 14, No 1
in
Quality Care Symposium
The Expanding Role of Molecular Targeted Therapies in Cholangiocarcinoma
Charlie Dawson
TOP - January 2021 Vol 14, No 1
in
Cholangiocarcinoma
Financial Toxicity Can Be Deadly for Patients with Cancer
Charlie Dawson
TOP - January 2021 Vol 14, No 1
in
Quality Care Symposium
Understanding Social Determinants of Health and Their Impact on Cancer Care
Charlie Dawson
TOP - January 2021 Vol 14, No 1
in
Quality Care Symposium
Multidisciplinary Cancer Care Starts and Ends with the Patient
Charlie Dawson
TOP - January 2021 Vol 14, No 1
in
Quality Care Symposium
The Value of Some Cancer Drugs Changes Substantially After Their Approval
Charlie Dawson
TOP - September 2020 Vol 13, No 5
in
Value-Based Care
Clinical Decision Support Helps Compliance with Evidence-Based Pathways
Charlie Dawson
TOP - September 2020 Vol 13, No 5
in
Value-Based Care
Intratumoral Administration of INT230-6 Improves Drug Diffusion and Uptake into Cancer Cells in Patients with Advanced Solid Tumors
Charlie Dawson
TOP - September 2020 Vol 13, No 5
in
Emerging Therapies
Pembrolizumab Doubles Progression-Free Survival in Subset of Patients with Metastatic Colorectal Cancer
Charlie Dawson
TOP - September 2020 Vol 13, No 5
in
Colorectal Cancer
Long-Term Data Support Use of Acalabrutinib in Patients with Treatment-Naïve CLL
Charlie Dawson
TOP - September 2020 Vol 13, No 5
in
Leukemia
Bortezomib, Lenalidomide, and Dexamethasone Remains Standard of Care for Initial Treatment of Patients with Newly Diagnosed Multiple Myeloma
Charlie Dawson
TOP - September 2020 Vol 13, No 5
in
Multiple Myeloma
CAR T-Cell Therapy Shows Deep, Durable Responses in Relapsed or Refractory Multiple Myeloma
Charlie Dawson
TOP - September 2020 Vol 13, No 5
in
Multiple Myeloma
Germline Analysis Proves Valuable in Selecting Targetable Treatments for Patients with Advanced Cancer
Charlie Dawson
TOP - September 2020 Vol 13, No 5
in
Value-Based Care
Cemiplimab Cost-Effective for Advanced Cutaneous Squamous-Cell Carcinoma
Charlie Dawson
TOP - September 2020 Vol 13, No 5
in
Value-Based Care
Last modified: August 17, 2020
Home
Issues
2022
May 2022 - Vol 15 No 3
March 2022 - Vol 15 No 2
January 2022 - Vol 15 No 1 – Online Only
2021
November 2021 - Vol 14 No 7
October 2021 - Vol 14 No 6 | Biosimilars
September 2021 - Vol 14 No 5
July 2021 - Vol 14 No 4
May 2021 - Vol 14 No 3
March 2021 - Vol 14 No 2
January 2021 - Vol 14 No 1
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
Issue Archive
Special Issues
Supplements
ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
Checkmate 9LA
Checkmate 227
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2021 Wrap-Up - Breast Cancer
Web Exclusives
Ovarian Cancer Overview
Interview with the Innovators
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
TOP
Print Edition
We will request your mailing address on the next page.
TOP
E-Newsletters and Communications
JHOP
Print Edition
We will request your mailing address on the next page.
JHOP
E-Newsletters and Communications
I have reviewed and consent to the terms of
TOP
's
Privacy Policy
, and
TOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
